MARINUS PHARMACEUTICALS, INC financial statements, including revenue, expenses, profit, and loss

The total revenue of MRNS for the last quarter is 168.29 M MXN, and it's 13.89% higher compared to the previous quarter. The net income of Q3 24 is -477.32 M MXN.